Aldeyra Therapeutics, Inc. · NASDAQ:ALDX
Brady Todd C bought 250,000 Aldeyra Therapeutics, Inc. shares (Form 4)
Traded Jun 3, 2026 · Filed Jun 5, 2026
On Jun 3, 2026, Brady Todd C (Director, President and CEO) bought 250,000 Aldeyra Therapeutics, Inc. shares at US$1.67 for US$418K, leaving 1,721,298 shares. Filed Jun 5, 2026 (Form 4).
- Bought
- 250,000 shares
- Price
- US$1.67
- Value
- US$418K
- Holding after
- 1,721,298 shares
- Trading plan
- No
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 3, 2026 | Common Stock | Buy | 250,000 | US$1.67 | 1,721,298 | Direct |
Source
Related
- Aldeyra Therapeutics, Inc.
- Brady Todd C
- Aldeyra Therapeutics, Inc. shareholders
- Schedule 13G · AQR Capital Management LLC · Aug 12, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G/A · Perceptive Advisors LLC · May 15, 2026
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Feb 17, 2026